When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time)
Health & MedicineOne-Off3mManifold MarketsSenza KYCDati di risoluzione verificatiDiscretamente calibratoPrevisione della comunità attualeDecember 2026 36%In testa tra 7 esiti
Previsori
6
Tipo di domanda
multiple choice
Metodologia
Play-money forecasting platform
Tipo di fonte
Previsione
Variazione 7g
0.0 pts
Dati di mercato
Aggiornato 1 ora fa
In ritardo7 lug 26, 22:11 UTC2 gen 27, 04:59 UTC
Trend
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
Intoxicating hemp-derived THC products federally banned in U.S. by end of 2026?
Manifold MarketsWill hemp-derived CBN sleep products still be federally legal as “hemp” on Nov 12, 2026?
Manifold MarketsWill Lego release a set for 'Fountain' by Duchamp by the end of 2030?
Manifold MarketsEbola pandemic in 2026?
PolymarketHantavirus pandemic in 2026?
PolymarketFDA approves skin cancer vaccine by which date?
PolymarketRegole
The FDA is under pressure to approve nicotine products under the PMTA (Premarket Tobacco Product Application) pathway.
- They have permitted products without FDA marketing authorization to remain available while the applications are under review.
- Resolution Criteria: Resolves to the FDA official website which lists authorizations
- Resolution Sources: .gov websites, official press releases
Mercati aperti
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No-0.3pt97%
- Yes+0.3pt3%
- Volume totale
- 15,6 Mln €
- Volume 24h
- 35,6K €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.9pt3%
- Volume totale
- 1,6 Mln €
- Volume 24h
- 5,2K €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+4.0pt65%
- September41%
- June28%
- Volume totale
- 83,5K €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000-1.0pt96%
- Above 6000-4.0pt58%
+2 altri esiti
- Volume totale
- 864,2K €
- Volume 24h
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Volume totale
- 915,8K €
- Volume 24h
- 1,5K €
KALSHIWhen will the FDA approve Intellia Therapeutics' lonvo-z?
- Before July 2027+67.0pt97%
- Before 202872%
- Before October 202752%
- Volume totale
- 4,2K €
- Volume 24h
- Will 3 mg THC beverages be federally legal to sell?
- Measles cases in U.S. in 2026?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- When will the FDA reclassify BPC-157 to Category 1?
- Ebola pandemic in 2026?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- Will the FDA approve CagriSema?
Domande frequenti
- Quali sono le probabilità attuali per When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time)?
- Manifold Markets quota December 2026 al 36% al 9 settembre 2026.
- Quando si risolve When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time)?
- When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time) dovrebbe risolversi il 2 gennaio 2027.
- Come viene liquidato When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time)?
- Manifold Markets liquida questo mercato come segue: The FDA is under pressure to approve nicotine products under the PMTA (Premarket Tobacco Product Application) pathway.